PET quantification of specific binding of carbon-11-nicotine in human brain

Journal of Nuclear Medicine

Volumn 39, Issue 12, 1998, Pages 2048-2054

  Muzic Jr , Raymond F ^a,b   Berridge, Marc S ^a   Friedland, Robert P ^a   Zhu, Ning ^a   Nelson, A Dennis ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Nicotine; Nicotinic binding sites; PET; Specific binding

Indexed keywords

BUTANOL; CARBON 11; NICOTINE; OXYGEN 15;

ARTICLE; BINDING SITE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CLINICAL TRIAL; COMPARTMENT MODEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DISTRIBUTION; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; NAUSEA; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

BLOOD-BRAIN BARRIER; BRAIN; BUTANOLS; CARBON RADIOISOTOPES; HUMANS; KINETICS; MODELS, NEUROLOGICAL; NICOTINE; OXYGEN RADIOISOTOPES; TIME FACTORS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032438052     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Aubert I, Araujo DM, Cecyre D, Robitaille Y, Gauthier S, Quirion R. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. J Neurochem 1992;58:529-541.
2. 3H]nicotine binding sites in human brain. J Neurochem 1988;50:1243-1247.
3. 3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains. Neurosci Lett 1986;72:115-119.
4. Kellar KJ, Whitehouse PJ, Martino-Barrows AM, Marcus K, Price DL. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex. Brain Res 1987;436:62-68.
5. 3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study. Neurology 1988;38:720-723.
6. Nordberg A, Adem A, Hardy J, Winblad B. Change in nicotinic receptor subtypes in temporal cortex of Alzheimer brains. Neurosci Lett 1988;86:317-321.
7. 3H-acetylcholine receptor autoradiography. J Neural Transm 1988;73:77-83.
8. Whitehouse PJ, Kalaria RN. Nicotinic receptors and neurodegenerative dementing diseases: basic research and clinical implications. Alzheimer Dis Assoc Disord 1995;9(suppl 2):3-5.
9. 11C]methionine. J Nucl Med 1987;28:1037-1040.
10. 11C]cotinine. Preparation, metabolite studies and in vivo distribution in the human brain using PET. Int J Rad Appl Instrum [B] 1992;19:871-880.
11. 11C-nicotine in brain of Alzheimer patients as visualized by positron emission tomography. J Neural Transm Park Dis Dement Sect 1990;2:215-224.
12. Nordberg A, Lilja A, Lundqvist H, et al. Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography. Neurobiol Aging 1992;13:747-758.
13. 11C-nicotine and positron emission tomography. Acta Radiol 1991;376(suppl)165-166.
14. Nybäck H, Nordberg A, Långström B, et al. Attempts to visualize nicotinic receptors in the brain of monkey and man by positron emission tomography. Prog Brain Res 1989;79:313-319.
15. 11C]nicotine in the human brain: difficulties in visualizing specific receptor binding in vivo. Psychopharmacology (Berl) 1994;115:31-36.
16. 11C-nicotine binding in normal and Alzheimer brains - in vivo assessment using positron emission tomography. Alzheimer Dis Assoc Disord 1995;9:21-27.
17. 11C]butanol. J Cereb Blood Flow Metab 1987;7:527-542.
18. 15O]butanol and positron emission tomography. J Cereb Blood Flow Metab 1991;11:707-715.
19. Wienhard K, Eriksson L, Grootoonk S, Casey M, Pietrzyk U, Heiss WD. Performance evaluation of the positron scanner ECAT EXACT. J Comput Assist Tomogr 1992;16: 804-813.
20. Nelson AD, Muzic RF Jr, Miraldi F, Muswick GJ, Leisure GP, Voelker W. Continuous arterial positron monitor for quantitation in PET imaging. Am J Physiol Imaging 1990;5:84-88.
21. 15O autoradiographic CBF model in PET. IEEE Trans Med Imag 1993;12:393-398.
22. Mintun MA, Raichle ME, Kilboum MR, Wooten GF, Welch MJ. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 1984;15:217-227.
23. Huesman RH. A new fast algorithm for the evaluation of regions of interest and statistical uncertainty in computed tomography. Phys Med Biol 1984;29:543-552.
24. Muzic RF Jr, Nelson AD, Saidel GM, Miraldi F. Optimal experiment design for PET quantification of receptor concentration. IEEE Trans Med Imaging 1996;15:2-12.
25. 11C]rac pride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab 1994;14:995-1010.
26. 11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 1991; 11:735-744.
27. 11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 1990;10:740-747.
28. 18F]cyclofoxy and positron emission tomography. J Cereb Blood Flow Metab 1993;13:24-42.
29. Landaw EM, DiStefano JJ. Multiexponential, multicompartmental, and noncompartmental modeling. II. Data analysis and statistical considerations. Am J Physiol 1984;246:R665-R677.
30. Shimohama S, Taniguchi T, Fujiwara M, Kameyama M. Biochemical characterization of the nicotinic cholinergic receptors in human brain: binding of (-)-[3H]nicotine. J Neurochem 1985;45:604-610.
31. Soderberg M, Edlund C, Alafuzoff I, Kristensson K, Dallner G. Lipid composition in different regions of the brain in Alzheimer's disease/senile dementia of Alzheimer's type. J Neurochem 1992;59:1646-1653.
32. Nordberg A, Alafuzoff I, Winblad B. Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. J Neurosci Res 1992;31:103-111.
33. Silvestrini M, Troisi E, Matteis M, Cupini LM, Bernardi G. Effect of smoking on cerebrovascular reactivity. J Cereb Blood Flow Metab 1996;16:746-749.
34. Pritchard WS, Robinson JH, deBethizy JD, Davis RA, Stiles MF. Caffeine and smoking: subjective, performance, and psychophysiological effects. Psychophysiology 1995;32:19-27.
35. Sherwood N. Effects of cigarette smoking on performance in a simulated driving task. Neuropsychobiology 1995;32:161-165.
36. Levin ED, Rose JE. Nicotinic and muscarinic interactions and choice accuracy in the radial-arm maze. Brain Res Bull 1991;27:125-128.